![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, November 05, 2019 5:12:25 PM
Enforcement Discretion for certain CBD products is de facto national legalization
In essence, the FDA would announce that they will permit national sales of CBD products as long as these products avoid making health claims and follow interim regulations
Technically speaking, CBD products would remain federally illegal, but the FDA would formally declare that they would only enforce the law if health claims were being made — practically speaking, this should greenlight national sales and open up banking, as the FDA-related legal risks of interstate commerce are largely erased and the fear of a federal crackdown on these products is removed
A declared FDA policy of formal enforcement discretion would have a number of positive effects on the national CBD industry, chief among them:
The distribution of CBD products would spread across the country in medical offices and retail stores
Financing for CBD businesses would open up
Investment in the CBD industry would increase
It sounds like a strange situation, but the FDA regularly applies the policy of enforcement discretion in situations like the current CBD conundrum, when more time is needed to create regulations around a product or device before it can legally enter the marketplace, but there is a need or demand for that product/device in the marketplace now — it’s basically a form of conditional legalization — “We will allow you to manufacture, distribute and sell these products as long as you follow these rules (interim regulations) and do not make health claims.”
— — —
So in terms of CBD products, we now know that a formal policy of Enforcement Discretion is expected to be declared in the FDA’s upcoming published report on CBD or in response to Mitch McConnell’s legislation
Here are what I believe to be the 2 most likely outcomes:
1) The Dr. Gottlieb Way — Pure CBD products only (No THC, No CBG/CBN/CBC)
FDA isn’t ready to federally legalize any CBD products yet, but creates interim regulations around Pure CBD products including specific formulation cutoffs for purity, potency and concentration, and announces a policy of enforcement discretion around these regulations
2) The McConnell Method — Only Pure CBD products are likely, but cannot completely rule out other options
If the FDA doesn’t announce enforcement discretion when they publish their report this Fall, Mitch has tied the FDA’s hands and forced them to announce a policy of enforcement discretion on at least one formulation of CBD products by January 2020:
https://hempindustrydaily.com/mcconnell-puts-pressure-on-fda-to-expedite-cbd-rules/
The most likely outcome here is The Gottlieb Way — interim regulations around Pure CBD products, including cutoffs for purity, potency, and concentration, with a formal policy of enforcement discretion
Another possible outcome is enforcement discretion for Pure CBD products with interim regulations but without specific cutoffs for purity, potency and concentration — “Enforcement discretion is for purified CBD products only — No THC and CBG/CBN/CBC allowed”
There is an outside chance that the FDA completely buckles to political pressure and declares blanket enforcement discretion for all CBD-based products, including those that contain up to .3% THC — in this scenario, there would probably not be any interim regulations around formulation criteria (potency, purity, concentration, etc) — this doesn’t make very much sense, because it really doesn’t move the process forward — it would also call into question why the FDA didn’t announce this policy right away in January 2019
In the most likely scenario where only Pure CBD products are given the green light, I don’t necessarily believe Full Spectrum and Broad Spectrum products will disappear
The FDA may very well continue to declare that CBD products with THC and/or CBG/CBN/CBC remain federally illegal and not offer any interim regulations or the protection of enforcement discretion for these products — if so, they could still announce a hands-off policy with respect to intrastate activity and allow states to create their own regulations around Full Spectrum products — national sales would remain prohibited
That would be the best case scenario for Full Spectrum and Broad Spectrum under a formal policy of Enforcement Discretion for Pure CBD products only
The worst case scenario for non-pure CBD product formulations like Full Spectrum and Broad Spectrum is a federal crackdown
That’s why Pure CBD products are the highest reward/lowest risk proposition in the CBD sector right now
VATE is superbly positioned with Pure CBD Coffee & Pure CBD Tea
For the home and on-the-go
Drink it hot or in chilled RTD Bottles and Cans
They have all the major segments of the Hemp & CBD Coffee and Tea markets very well covered
https://www.instagram.com/p/B4XlQZxhWfC/
Sleek
SLEEKSCAPE’S GRAND SALAMI FOR 2020 HEMP & CBD MANIA -- PART II
https://investorshub.advfn.com/$LEEK$CAPE’S-2020-HEMP-CBD-&-MARIJUANA-MANIA-GRAND-SALAMI-PART-II-31243/
Recent BLEG News
- Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • InvestorsHub NewsWire • 06/27/2024 12:30:00 PM
- Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • InvestorsHub NewsWire • 05/30/2024 12:30:00 PM
- Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • InvestorsHub NewsWire • 05/22/2024 12:30:00 PM
- Branded Legacy Inc. Invites Shareholders to Celebrate Milestones at Open House: Announces Share Buyback and Commitment to Authorized Share Count • InvestorsHub NewsWire • 05/15/2024 12:30:00 PM
- Branded Legacy, Inc. Reports Significant Net Income of Over $3.8 Million • InvestorsHub NewsWire • 04/16/2024 12:30:00 PM
- Branded Legacy, Inc. To Add $320,000 In Revenue With New White Label Contract • InvestorsHub NewsWire • 04/09/2024 12:30:00 PM
- Branded Legacy, Inc Announces White Label Deal with Kava & Hobbs, LLC for Kava Vape formulation • InvestorsHub NewsWire • 04/04/2024 12:30:00 PM
- Branded Legacy, Inc. Significantly Expands Asset Portfolio and Production Capacity Through Successful Acquisition of Sycamore BioPharma, Inc. • InvestorsHub NewsWire • 03/12/2024 01:54:43 PM
- Shares of this Biotech Holdings Company Up on LOI • AllPennyStocks.com • 02/29/2024 06:10:00 PM
- Branded Legacy, Inc. Strengthens Position in BioTech Industry with Letter of Intent to Purchase Sycamore BioPharma, LLC • InvestorsHub NewsWire • 02/29/2024 01:30:00 PM
- Branded Legacy, Inc. Expands Operations with Move to State of the Art Biotech Facility in Melbourne, FL • InvestorsHub NewsWire • 02/08/2024 01:30:00 PM
- Branded Legacy, Inc. Innovates with Launch of the First 100% Clear Kava-Based Vaping Product on the Market • InvestorsHub NewsWire • 02/06/2024 02:30:00 PM
- Branded Legacy, Inc. Unveils Major Equipment Acquisition Raising Total Assets to $3,787,215.00 • InvestorsHub NewsWire • 01/30/2024 02:25:00 PM
- Branded Legacy, Inc. Reduces Debt by 1.5 Million • InvestorsHub NewsWire • 01/25/2024 01:30:00 PM
- Branded Legacy, Inc. ($BLEG) Announces Reduction in Authorized Share Count to 900M • InvestorsHub NewsWire • 01/23/2024 01:30:00 PM
- Branded Legacy, Inc. (BLEG) Expands Portfolio with Comprehensive Acquisition of MariJ Pharmaceuticals Inc, Including Licenses, Organic Certifications, and Substantial Assets • InvestorsHub NewsWire • 12/05/2023 01:00:00 PM
- Branded Legacy Commences Buyback of 1,000,000 Preferred Class D Shares • InvestorsHub NewsWire • 11/28/2023 12:23:33 PM
- Branded Legacy Signs Letter of Intent to Acquire $6 Million in Assets and Additional Facility Space • InvestorsHub NewsWire • 11/16/2023 12:00:00 PM
- Branded Legacy, Inc. Announces 1.5B Reduction in Authorized Share Count • InvestorsHub NewsWire • 11/09/2023 12:03:15 PM
- Branded Legacy, Inc. Secures $1M Line of Credit, Affirms No Reverse Split, and Previews Upcoming Investor Engagements • InvestorsHub NewsWire • 11/07/2023 12:02:43 PM
- Branded Legacy Takes Bold Step in Strengthening Shareholder Value: Retires 1 Billion Common Shares This Week, With More to Follow • InvestorsHub NewsWire • 10/26/2023 12:30:00 PM
- Rocket Web Development & Design: Navigating the Digital Frontier with Innovation and Excellence • InvestorsHub NewsWire • 10/24/2023 01:00:00 PM
- Branded Legacy, Inc. Has Retired 600 Million Common Shares on Path to Retire 2 Billion by November 2023 • InvestorsHub NewsWire • 10/19/2023 12:00:00 PM
- Branded Legacy Completes Acquisition of The Alcannabist, Signifying Business Expansion • InvestorsHub NewsWire • 10/10/2023 12:25:00 PM
- Total Refinement Solutions LLC Transitions to Royal Biotek Under $BLEG Portfolio • InvestorsHub NewsWire • 10/05/2023 12:18:33 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM